Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:950
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
LETTER TO THE EDITOR  
Year : 2015  |  Volume : 8  |  Issue : 3  |  Page : 71-72
Neuraminidase inhibitor resistance of the isolated influenza virus: Analysis of 54-month data from Thailand


1 Department of Medical Science, KMT Medical Center, Bangkok, Thailand
2 Department of Tropical Medicine, Hainan Medical University, Hainan, China; Joseph Ayo Babalola University, Osun State, Nigeria; University of Nis, Nis, Serbia; Dr DY Patil Medical University, Pune, Maharashtra, India; Surin Rajabhat University, Surin, Thailand

Click here for correspondence address and email

Date of Web Publication25-May-2015
 

How to cite this article:
Yasri S, Wiwanitkit V. Neuraminidase inhibitor resistance of the isolated influenza virus: Analysis of 54-month data from Thailand. Ann Trop Med Public Health 2015;8:71-2

How to cite this URL:
Yasri S, Wiwanitkit V. Neuraminidase inhibitor resistance of the isolated influenza virus: Analysis of 54-month data from Thailand. Ann Trop Med Public Health [serial online] 2015 [cited 2019 Aug 20];8:71-2. Available from: http://www.atmph.org/text.asp?2015/8/3/71/157636
Dear Sir,

At present, acute febrile illness due to influenza virus infection has become a public concern. The infection can be seen worldwide and is the focus of disease surveillance and control by the World Health Organization (WHO). An interesting issue of the influenza virus study, at present, is the emergence of the drug resistance strain. The drug-resistant influenza can be problematic and difficult to treat. [1] The monitoring of drug resistance is an interesting aspect of laboratory study. However, due to its high cost, it is not routinely done in the developing countries. Here, the authors have tried to analyze the primary data in the official report from the Thai National Influenza Center, Thailand. [2] The data on the neuraminidase inhibitor resistance test of the isolated influenza virus within the period between January 2009 and May 2013 were collected. Interestingly, within the studied period of 53 months, there were 1,600 studied isolations and 0.68% were neuraminidase inhibitor resistant. Classified by subgroup, the resistance can be seen in 0%, 0%, 1.36%, and 99.55% of influenza B, influenza A virus subtype H3N2 (H3N2), the new emerging influenza A (H1N1), and the classical H1N1, respectively. It can be seen that the resistance was in only the H1N1s. In this report, the rate is higher than the one observed at a single center in Thailand (about 0.31%). [3] This shows the fact that the presently used neuraminidase inhibitor will be little useful for fighting H1N1 influenza in Thailand.

 
   References Top

1.
Hurt AC. The epidemiology and spread of drug resistant human influenza viruses. Curr Opin Virol 2014;8:22-9.  Back to cited text no. 1
    
2.
Thai Department of Medical Science. News Letter. Dept Med Sci Lett 2013;27:5.  Back to cited text no. 2
    
3.
Payungporn S, Poomipak W, Makkoch J, Rianthavorn P, Theamboonlers A, Poovorawan Y. Detection of oseltamivir sensitive/resistant strains of pandemic influenza A virus (H1N1) from patients admitted to hospitals in Thailand. J Virol Methods 2011;177:133-9.  Back to cited text no. 3
    

Top
Correspondence Address:
Dr. Sora Yasri
Department of Medical Center, KMT Medical Center, Bangkok
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1755-6783.157636

Rights and Permissions




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *


    References

 Article Access Statistics
    Viewed716    
    Printed15    
    Emailed0    
    PDF Downloaded13    
    Comments [Add]    

Recommend this journal